LGALS3 and thyroiditis: In this study, our goal was to evaluate the usefulness of using four of the most promising IHC markers (galectin-3, HBME-1, CK19, and Ret oncoprotein) on FNA cell block sections of thyroid lesions to identify the most helpful marker(s) in separating benign from malignant nodules.